Source: International Congress 2014 – ILDs 3
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ojanguren, M. J. Cruz, A. Villar, F. Morell, X. Muñoz (Barcelona, Spain). Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis. Eur Respir J 2014; 44: Suppl. 58, 783

Member's Comments

No comment yet.

Related content which might interest you: Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Treatment response in hypersensitivity pneumonitis Source: International Congress 2016 – Orphan diseases II Year: 2016 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014 Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD) Source: International Congress 2014 – ILDs 5 Year: 2014 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Exhaled particles from small airways in COPD patients – A pilot study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Acidity of the exhaled breath condensate in assessing bronchial challenge with exercise in children: Effect of deaeration Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005 Can Scond and Sacin be estimated from two multiple breath washout tests across childhood? Source: International Congress 2015 – Paediatric respiratory physiology Year: 2015 MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020